( July 14, 2025, 11:48 AM EDT) -- NEW ORLEANS — The U.S. Food and Drug Administration on July 13 sent a letter to the Fifth Circuit U.S. Court of Appeals stating that it intends to narrow the issues requiring review and voluntarily review the marketing plans of two e-liquid companies, as that was one of the issues remanded to the Fifth Circuit by the U.S. Supreme Court after it found that FDA did not improperly change its standards for e-cigarette product reviews....